Bulletin
Investor Alert

New York Markets Open in:

Harrow Health Inc.

NAS: HROW

GO
/marketstate/country/us

Market closed

 --Quotes are delayed by 20 min

Dec 3, 2021, 4:00 p.m.

/zigman2/quotes/206805265/composite

$

9.35

Change

-0.38 -3.91%

Volume

Volume 79,410

Quotes are delayed by 20 min

/zigman2/quotes/206805265/composite

Previous close

$ 9.73

$ 9.35

Change

-0.38 -3.91%

Day low

Day high

$9.28

$9.79

Open

52 week low

52 week high

$5.13

$12.99

Open

John P. Saharek

John P. Saharek is President-ImprimisRx at Harrow Health, Inc.

In the past he was Vice President-Business Development for SurModics, Inc. and Head-US Marketing & Strategy at Thrombogenics, Inc.

He received an MBA from the University of Hartford and an undergraduate degree from Central Connecticut State University.

Transactions

Date Shares Transaction Value
02/01/2018 30,000   Derivative/Non-derivative trans. at $1.83 per share. 54,900

Officers and Executives

Mr. Mark L. Baum
Chairman & Chief Executive Officer
Mr. Andrew R. Boll
Chief Financial Officer & Secretary
Dr. Larry M. Dillaha
Chief Medical Officer
Mr. Andrew Livingston
Chief Innovation Officer
Mr. John P. Saharek
President-ImprimisRx
Dr. Richard L. Lindstrom
Director
Ms. Teresa F. Sparks
Independent Director
Dr. R. Lawrence Van Horn
Independent Director
Dr. Robert J. Kammer
Independent Director
Trending Tickers
  • /zigman2/quotes/200467500/composite NVDA+6.20%
  • /zigman2/quotes/201948298/composite BABA-5.69%
  • /zigman2/quotes/202092269/composite ENSC+36.10%
  • /zigman2/quotes/200164174/composite SNOA+74.50%
  • /zigman2/quotes/207683784/composite TIGR-10.38%
X
Powered by StockTwits
Link to MarketWatch's Slice.